Cite
Systemic telomere length and preclinical atherosclerosis: the Asklepios Study.
MLA
De Meyer, Tim, et al. “Systemic Telomere Length and Preclinical Atherosclerosis: The Asklepios Study.” European Heart Journal, vol. 30, no. 24, Dec. 2009, pp. 3074–81. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=47152513&authtype=sso&custid=ns315887.
APA
De Meyer, T., Rietzschel, E. R., De Buyzere, M. L., Langlois, M. R., De Bacquer, D., Segers, P., Van Damme, P., De Backer, G. G., Van Oostveldt, P., Van Criekinge, W., Gillebert, T. C., & Bekaert, S. (2009). Systemic telomere length and preclinical atherosclerosis: the Asklepios Study. European Heart Journal, 30(24), 3074–3081.
Chicago
De Meyer, Tim, Ernst R. Rietzschel, Marc L. De Buyzere, Michel R. Langlois, Dirk De Bacquer, Patrick Segers, Piet Van Damme, et al. 2009. “Systemic Telomere Length and Preclinical Atherosclerosis: The Asklepios Study.” European Heart Journal 30 (24): 3074–81. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=47152513&authtype=sso&custid=ns315887.